Franklin Resources
PCRX icon

Franklin Resources’s Pacira BioSciences PCRX Stock Holding History

Franklin Resources’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,922
Closed -$744K – 3304
2026
Q1 		$744K Sell
32,922
-938
-3% -$20.8K ﹤0.01% 2304
2025
Q4 		$876K Buy
33,860
+846
+3% +$20.1K ﹤0.01% 2152
2025
Q3 		$851K Buy
33,014
+1,954
+6% +$48K ﹤0.01% 2192
2025
Q2 		$742K Buy
31,060
+2,949
+10% +$74.3K ﹤0.01% 2136
2025
Q1 		$699K Buy
+28,111
New +$673K ﹤0.01% 2124
2024
Q3 		– Sell
-9,258
Closed -$265K – 2995
2024
Q2 		$265K Buy
+9,258
New +$263K ﹤0.01% 2473
2023
Q4 		– Sell
-7,687
Closed -$236K – 2696
2023
Q3 		$236K Buy
+7,687
New +$277K ﹤0.01% 2256
2022
Q4 		– Sell
-5,049
Closed -$269K – 2367
2022
Q3 		$269K Buy
5,049
+190
+4% +$10.6K ﹤0.01% 1894
2022
Q2 		$283K Sell
4,859
-271
-5% -$17.8K ﹤0.01% 1893
2022
Q1 		$392K Buy
5,130
+962
+23% +$64.1K ﹤0.01% 1917
2021
Q4 		$251K Buy
4,168
+98
+2% +$5.4K ﹤0.01% 2159
2021
Q3 		$228K Buy
+4,070
New +$235K ﹤0.01% 2190
2015
Q3 		– Sell
-19,336
Closed -$1.37M – 1616
2015
Q2 		$1.37M Buy
19,336
+697
+4% +$54.9K ﹤0.01% 1369
2015
Q1 		$1.66M Buy
18,639
+2,030
+12% +$206K ﹤0.01% 1342
2014
Q4 		$1.47M Buy
+16,609
New +$1.57M ﹤0.01% 1353
2014
Q3 		– Sell
-17,245
Closed -$1.58M – 1580
2014
Q2 		$1.58M Sell
17,245
-165,280
-91% -$12.6M ﹤0.01% 1321
2014
Q1 		$12.8M Buy
182,525
+10,800
+6% +$735K 0.01% 968
2013
Q4 		$9.87M Sell
171,725
-463,095
-73% -$24.4M ﹤0.01% 990
2013
Q3 		$30.5M Sell
634,820
-298,900
-32% -$10.9M 0.02% 686
2013
Q2 		$27.1M Buy
+933,720
New +$27M 0.02% 685

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's PCRX Position: Q2 2026 in Review

Franklin Resources sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 32,922 shares — an estimated $744K sold.

Franklin Resources first reported a position in PCRX in Q2 2013 and held it in 20 quarters. The position peaked at $30.5M in Q3 2013. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Franklin Resources reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Franklin Resources sold 32,922 Pacira BioSciences shares in Q2 2026, an estimated $744K.
  • Franklin Resources first reported a position in Pacira BioSciences in Q2 2013 and held it in 20 quarters.
  • Franklin Resources's Pacira BioSciences position peaked at $30.5M in Q3 2013.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.